Hyperproinsulinemia segregates young adult patients with newly diagnosed autoimmune (type 1) and non-autoimmune (type 2) diabetes

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 65, Issue 7, 2005, Pages 585-594

  Bolinder, J ^a   Fernlund, P ^c   Borg, H ^c   Arnqvist, H J ^d   Bjork E ^e   Blohme G ^b   Eriksson, J W ^f   Nystrom L ^g   Ostman J ^a   Sundkvist, G ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b STOCKHOLM SÖDER HOSPITAL   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^e UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^f UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^g UMEÅ UNIVERSITY   (Sweden)

Author keywords

Diabetes classification; GADA; IA 2A; ICA; Split proinsulin

Indexed keywords

AUTOANTIBODY; INSULIN; ORAL ANTIDIABETIC AGENT; PROINSULIN;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE DISEASE; CIRCULATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIET THERAPY; FEMALE; GENDER; HUMAN; INSULIN BLOOD LEVEL; INSULIN DEGRADATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULINEMIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PANCREAS ISLET; PRIORITY JOURNAL;

ADOLESCENT; ADULT; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERINSULINISM; INSULIN; MALE;

EID: 31544468414     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00365510500261869     Document Type: Article

References (32)

1. American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997;20:1183-97.
2. Alberti KGMM, Zimmet PZ, for the WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. I. Diagnosis and classification of diabetes mellitus: provisional report of a WHO Consultation. Diabet Med 1998;15:539-53.
3. Rosenbloom AL, Joe JR, Young RS, Winter WE. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999;22:345-54.
4. Pozzilli P, Di Mario U. Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult). Diabetes Care 2001;24:1460-7.
5. Landin-Olsson M, Arnqvist HJ, Blohmé G, Littorin B, Lithner F, Nyström L, et al. Appearance of islet cell autoantibodies after clinical diagnosis of diabetes mellitus. Autoimmunity 1999;29:57-63.
6. Decochez K, Tits J, Coolens J-L, van Gaal L, Krzentowski G, Winnock F, et al. High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. Diabetes Care 2000;23:838-44.
7. Borg H, Arnqvist HJ, Björk E, Bolinder J, Eriksson JW, Nyström L, et al. Evaluation of the new ADA and WHO criteria for classification of diabetes mellitus in young adult people (15-34 yrs) in the Diabetes Incidence Study in Sweden (DISS). Diabetologia 2003;36:173-81.
8. Arnqvist HJ, Littorin B, Nyström L, Scherstén B, Östman J, Blohmé G, et al. Difficulties in classifying diabetes at presentation in the young adult. Diabet Med 1993;10:606-13.
9. Tuomi T, Carlsson A, Li H, Isomaa B, Miettinen A, Nilsson A, et al. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 1999;48:150-7.
10. Törn C, Landin-Olsson M, Ostman J, Scherstén B, Arnqvist H, Blohmé G, et al. Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as type 1 diabetes on clinical grounds. Diabetes Metab Res Rev 2000;16:442-7.
11. Gordon P, Hendricks CM, Roth J. Circulating proinsulin-like component in man: increased proportion in hypoinsulinemic states. Diabetologia 1974;10:469-74.
12. Temple RC, Carrington CA, Luzio SD, Owens DR, Schneider AE, Sobey WJ, et al. Highly specific insulin assay reveals uniform insulin deficiency in non-insulin-dependent diabetics. Lancet 1989;i:1648-9.
13. Saad MF, Kahn SE, Nelson RG, Pettitt DJ, Knowler WC, Schwartz MW, et al. Disproportionately elevated proinsulin in Pima Indians with non-insulin- dependent diabetes mellitus. J Clin Endocrinol Metab 1990;70:1247-53.
14. Kahn SE, Halban PA. Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of type 2 diabetes. Diabetes 1997;46:1725-32.
15. Röder ME, Porte D, Schwartz RS, Kahn SE. Disproportionately elevated proinsulin levels reflect the degree of impaired β-cell secretory capacity in patients with non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1998;83:604-8.
16. Pfutzner A, Kunt T, Hohberg C, Mondok A, Pahler S, Konrad T, et al. Fasting intact proinsulin is a highly specific predictor of insulin resistance in type 2 diabetes. Diabetes Care 2004;27:682-7.
17. Davies MJ, Rayman G, Gray IP, Day JL, Hales CN. Insulin deficiency and increased plasma concentration of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance. Diabet Med 1993;10:313-20.
18. Haffner SM, Gonzales C, Mykkanen L, Stern M. Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: the Mexico City Diabetes Study. Diabetologia 1997;40:830-7.
19. Nijpels G, Popp-Snijders C, Kostense PJ, Bouter LM, Heine RJ. Fasting proinsulin and 2-hour post-load glucose concentrations predict the conversion to NIDDM in subjects with impaired glucose tolerance: the Hoorn Study. Diabetologia 1996;39:113-8.
20. Wareham NJ, Byrne CD, Williams R, Day NE, Hales CN. Fasting proinsulin concentrations predict the development of type 2 diabetes. Diabetes Care 1999;22:262-70.
21. Zethelius B, Hales CN, Lithell H, Berne C. Insulin resistance, impaired early insulin response, and insulin propeptides as predictors of the development of type 2 diabetes: a population-based, 7-year follow-up study in 70-year-old men. Diabetes Care 2004;27:1433-8.
22. Landin-Olsson M, Sundkvist G, Lernmark Å. Prolonged incubation in the two-colour immunofluorescence test increases the prevalence and titres of islet cell antibodies in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987;30:327-32.
23. 125I assays compared with [35S]GAD 65-ligand binding assay. Clin Chem 1997;43:779-85.
24. Borg H, Fernlund P, Sundkvist G. Protein tyosine phosphatase-like protein IA2-antibodies plus glutamic acid decarboxylase 65 antibodies (GADA) indicates autoimmunity as frequently as islet cell antibodies assay in children with recently diagnosed diabetes mellitus. Clin Chem 1997;43:2358-63.
25. Kjems LL, Röder ME, Dinesen B, Hartling SG, Jörgensen PN, Binder C. Highly sensitive enzyme immunoassay of proinsulin immunoreactivity with use of two monoclonal antibodies. Clin Chem 1993;39:2146-50.
26. Sobey WJ, Beer SF, Carrington CA, Clark PM, Frank BH, Gray IP, et al. Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins. Biochem J 1989;260:535-41.
27. Gottsäter A, Owens DR, Luzio S, Sundkvist G. Proinsulin secretion during the first 3 years after diagnosis in diabetic patients with or without islet cell antibodies. Diabetes Care 1996;19:659-62.
28. Nauck MA, Siegel EG, Creutzfeldt W. Prolonged maximal stimulation of insulin secretion in healthy subjects does not provoke preferential release of proinsulin. Pancreas 1991;6:645-52.
29. Hartling SG, Röder ME, Dinesen B, Binder C. Proinsulin, C-peptide and insulin in normal subjects during eight hours hyperglycemic clamp. Eur J Endocrinol 1996;134:197-200.
30. Törn C, Landin-Olsson M, Lernmark Å, Scherstén B, Östman J, Arnqvist HJ, et al. Combinations of beta-cell specific autoantibodies at diagnosis of diabetes in young adults reflect different courses of beta-cell damage. Autoimmunity 2001;33:115-20.
31. Hartling SG, Lindgren F, Dahlqvist G, Persson B, Binder C. Elevated proinsulin in healthy siblings of IDDM patients independent of HLA identity. Diabetes 1989;38:1271-4.
32. Lindgren FA, Hartling SG, Dahlqvist GG, Binder C, Efendic S, Persson BE. Glucose-induced insulin response is reduced and proinsulin response increased in healthy siblings of type 1 diabetic patients. Diabet Med 1991;8:638-43.